Literature DB >> 27977083

The 2014 Survey on Living with Chronic Diseases in Canada on Mood and Anxiety Disorders: a methodological overview.

S O'Donnell1, R Cheung1, K Bennett2, C Lagacé1.   

Abstract

INTRODUCTION: There is a paucity of information about the impact of mood and anxiety disorders on Canadians and the approaches used to manage them. To address this gap, the 2014 Survey on Living with Chronic Diseases in Canada-Mood and Anxiety Disorders Component (SLCDC-MA) was developed. The purpose of this paper is to describe the methodology of the 2014 SLCDC-MA and examine the sociodemographic characteristics of the final sample.
METHODS: The 2014 SLCDC-MA is a cross-sectional follow-up survey that includes Canadians from the 10 provinces aged 18 years and older with mood and/or anxiety disorders diagnosed by a health professional that are expected to last, or have already lasted, six months or more. The survey was developed by the Public Health Agency of Canada (PHAC) through an iterative, consultative process with Statistics Canada and external experts. Statistics Canada performed content testing, designed the sampling frame and strategies and collected and processed the data. PHAC used descriptive analyses to describe the respondents' sociodemographic characteristics, produced nationally representative estimates using survey weights provided by Statistics Canada, and generated variance estimates using bootstrap methodology.
RESULTS: The final 2014 SLCDC-MA sample consists of a total of 3361 respondents (68.9% response rate). Among Canadian adults with mood and/or anxiety disorders, close to twothirds (64%) were female, over half (56%) were married/in a common-law relationship and 60% obtained a post-secondary education. Most were young or middle-aged (85%), Canadian born (88%), of non-Aboriginal status (95%), and resided in an urban setting (82%). Household income was fairly evenly distributed between the adequacy quintiles; however, individuals were more likely to report a household income adequacy within the lowest (23%) versus highest (17%) quintile. Forty-five percent reported having a mood disorder only, 24% an anxiety disorder only and 31% both kinds of disorder.
CONCLUSION: The 2014 SLCDC-MA is the only national household survey to collect information on the experiences of Canadians living with a professionally diagnosed mood and/or anxiety disorder. The information collected offers insights into areas where additional support or interventions may be needed and provides baseline information for future public health research in the area of mental illness.

Entities:  

Keywords:  anxiety disorders; disease management; health surveys; mental health impacts; mood disorders; population surveillance; survey methodology; survey on Living with Chronic Diseases in Canada

Mesh:

Year:  2016        PMID: 27977083      PMCID: PMC5387795          DOI: 10.24095/hpcdp.36.12.02

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  38 in total

Review 1.  Pretesting survey instruments: an overview of cognitive methods.

Authors:  Debbie Collins
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

2.  [A validation of the Social Provisions Scale: the SPS-10 items].

Authors:  Jean Caron
Journal:  Sante Ment Que       Date:  2013

3.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

4.  Why wait? Reasons for delay and prompts to seek help for mental health problems in an Australian clinical sample.

Authors:  Anna Thompson; Caroline Hunt; Cathy Issakidis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-10       Impact factor: 4.328

5.  Summary health statistics for the U.S. population: National Health Interview Survey, 2012.

Authors:  Patricia F Adams; Whitney K Kirzinger; Michael Martinez
Journal:  Vital Health Stat 10       Date:  2013-12

6.  Concordance between self-report and a survey-based algorithm for classification of type 1 and type 2 diabetes using the 2011 population-based Survey on Living with Chronic Diseases in Canada (SLCDC)-Diabetes component.

Authors:  Edward Ng; Saskia E Vanderloo; Linda Geiss; Jeffrey A Johnson
Journal:  Can J Diabetes       Date:  2013-08-02       Impact factor: 4.190

Review 7.  Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.

Authors:  C Lindsay Devane; Evelyn Chiao; Meg Franklin; Eric J Kruep
Journal:  Am J Manag Care       Date:  2005-10       Impact factor: 2.229

Review 8.  The treatment gap in mental health care.

Authors:  Robert Kohn; Shekhar Saxena; Itzhak Levav; Benedetto Saraceno
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 10.  Marital status, health and mortality.

Authors:  James Robards; Maria Evandrou; Jane Falkingham; Athina Vlachantoni
Journal:  Maturitas       Date:  2012-09-21       Impact factor: 4.342

View more
  6 in total

1.  Health status, activity limitations, work-related restrictions and level of disability among Canadians with mood and/or anxiety disorders.

Authors:  L Loukine; S O'Donnell; E M Goldner; L McRae; H Allen
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-12       Impact factor: 3.240

2.  Correlates of well-being among Canadians with mood and/or anxiety disorders.

Authors:  H Orpana; J Vachon; C Pearson; K Elliott; M Smith; B Branchard
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-12       Impact factor: 3.240

3.  Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders.

Authors:  Siobhan O'Donnell; Maria Syoufi; Wayne Jones; Kathryn Bennett; Louise Pelletier
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-05       Impact factor: 3.240

4.  Introduction.

Authors:  Siobhan O'Donnell
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-05       Impact factor: 3.240

5.  Factors associated with delayed diagnosis of mood and/or anxiety disorders.

Authors:  Ricky Cheung; Siobhan O'Donnell; Nawaf Madi; Elliot Goldner
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-05       Impact factor: 3.240

6.  Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis.

Authors:  Nibene Habib Somé; Samantha Wells; Daniel Felsky; Hayley A Hamilton; Shehzad Ali; Tara Elton-Marshall; Jürgen Rehm
Journal:  BMC Psychiatry       Date:  2022-04-30       Impact factor: 4.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.